Origin Therapeutics Holdings (XCNQ:ORIG) Price-to-Owner-Earnings : (As of Jun. 09, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Price-to-Owner-Earnings?

As of today (2024-06-09), Origin Therapeutics Holdings's share price is C$0.025. Origin Therapeutics Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for Origin Therapeutics Holdings's Price-to-Owner-Earnings or its related term are showing as below:

XCNQ:ORIG's Price-to-Owner-Earnings is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 25.31
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-09), Origin Therapeutics Holdings's share price is C$0.025. Origin Therapeutics Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was C$-0.05. Therefore, Origin Therapeutics Holdings's PE Ratio for today is At Loss.

As of today (2024-06-09), Origin Therapeutics Holdings's share price is C$0.025. Origin Therapeutics Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.01. Therefore, Origin Therapeutics Holdings's PE Ratio without NRI for today is At Loss.

Origin Therapeutics Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Origin Therapeutics Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Price-to-Owner-Earnings Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Price-to-Owner-Earnings

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Price-to-Owner-Earnings	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Origin Therapeutics Holdings's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Price-to-Owner-Earnings falls into.

Origin Therapeutics Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Origin Therapeutics Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	0.025	/	0.00
	=

Origin Therapeutics Holdings (XCNQ:ORIG) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Origin Therapeutics Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.